International Journal of STD & AIDS > Volume 16, Number 8 > Pp. 546-548

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Salazar, L. F Articles by Peterson, J. L Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Original Research Article

Issues related to gay and bisexual men's acceptance of a future AIDS vaccine

Laura F Salazar, David Holtgrave, Richard A Crosby, Paula Frew and John L Peterson

Emory University, Rollins School of Public Health, Department of Behavioral Sciences & Health Education, 1518 Clifton Road NE, 5th floor, Atlanta, GA 30322, USA; Emory University, Rollins School of Public Health, Department of Behavioral Sciences & Health Education, 1518 Clifton Road NE, 5th floor, Atlanta, GA 30322, USA; Emory Center for AIDS Research, Atlanta, GA, USA; Emory University, Rollins School of Public Health, Department of Behavioral Sciences & Health Education, 1518 Clifton Road NE, 5th floor, Atlanta, GA 30322, USA; Emory Center for AIDS Research, Atlanta, GA, USA; Emory University, Rollins School of Public Health, Department of Behavioral Sciences & Health Education, 1518 Clifton Road NE, 5th floor, Atlanta, GA 30322, USA; The Hope Clinic of the Emory Vaccine Center, Atlanta, GA, USA; Georgia State University, Department of Psychology, Atlanta, GA, USA

The purpose of this study was to identify the salient issues related to getting a future AIDS vaccine among a high-risk group. In-depth interviews were conducted with 24 White and Black men who have sex with men (MSM). Participants reported that they would need information regarding the vaccine strategy, the clinical trials research, and vaccine attributes. A prerequisite for Black participants was the prior inclusion of Blacks in clinical trials. A high degree of safety and effectiveness, minimal side-effects, high-perceived risk, and affordable cost would promote vaccine acceptance. Barriers were low degree of safety and effectiveness, harsh side-effects, low-perceived risk, perception of a backlash effect, cost, and inconvenience. MSM may not readily get an AIDS vaccine unless they are provided with specific details and the benefits outweigh the costs. Researchers conducting HIV vaccine trials should provide information about the research and insure that samples represent Black men.

Key Words: AIDS VACCINE • HIV VACCINE • QUALITATIVE RESEARCH • HIV/AIDS • MSM

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?